OncoMatch/Clinical Trials/NCT03925662
Mebendazole as Adjuvant Treatment for Colon Cancer
Is NCT03925662 recruiting? Yes, currently enrolling (May 2026). This Phase 3 trial studies multiple treatments including Folfox with avastin and Mebendazole for colorectal cancer.
Treatment: Folfox with avastin · Mebendazole — mebendazole treating colon cancer
Check if I qualifyExtracted eligibility criteria
Cancer type
Colorectal Cancer
Disease stage
Required: Stage IV
Colorectal cancer stage 4.
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify